MMP9 and plasma cell myeloma: Specifically, treatment with myeloma-derived EVs promoted increased cell spreading and migration of endothelial cells through a Matrigel basement membrane by 1.5-fold, indicating that the EVs promote modulation of the matrix via MMP-9 and reprogram the healthy cells towards a more cancerous phenotype [64].